Knee Osteoarthritis Outcome Measures in Arthritic Patients With Osteoporosis

NCT03217513 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2019-10-24

No results posted yet for this study

Summary

The purpose of this study is to generate proof of concept human data by evaluating osteoarthritis outcome measures in arthritic patients that are prescribed Forteo® as the standard of care to treat their primary diagnosis of osteoporosis.

Conditions

Sponsors & Collaborators

  • Edward Fox

    lead OTHER

Principal Investigators

  • Edward J Fox, M.D. · Milton S. Hershey Medical Center

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2023-12-31
Completion
2024-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03217513 on ClinicalTrials.gov